To evaluate if RNF144B expression is TP53 dependent, we classified tumour tissue samples from GDC and TCGA datasets as TP53-deficient and TP53-proficient, based on their TP53 status (Supplementary Table 1). This evidence concerns the gene TP53 and neoplasm.